Therapeutic potential of Terminalia arjuna in cardiovascular disorders

American Journal of Cardiovascular Drugs

Volumn 12, Issue 3, 2012, Pages 157-163

  Maulik, Subir K ^a   Talwar, Kewal K ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b National Academy of Medical Sciences   (India)

Author keywords

Cardiovascular disorders; Herbal medicines

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA TOCOPHEROL; ASCORBIC ACID; ATENOLOL; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; CHOLESTEROL; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOSORBIDE MONONITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; PLACEBO; PROSTAGLANDIN E2; TERMINALIA ARJUNA EXTRACT; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BARK; BODY MASS; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; EXERCISE TOLERANCE; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOLIPEMIA; IN VITRO STUDY; IN VIVO STUDY; INOTROPISM; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; MITRAL VALVE REGURGITATION; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT DEPRESSION; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE; TERMINALIA ARJUNA; THROMBOCYTE AGGREGATION; TREADMILL EXERCISE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

ANIMALS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; MEDICINE, AYURVEDIC; PLANT BARK; PLANT EXTRACTS; TERMINALIA;

EID: 84861323319     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11598990-000000000-00000     Document Type: Review

References (40)

1. Reddy KS, Satija A. The Framingham Heart Study: impact on the prevention and control of cardiovascular diseases in India. Prog Cardiovasc Dis 2010; 53 (1): 21-7
2. Daviglus ML, Lloyd-Jones DM, Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am J Cardiovasc Drugs 2006; 6 (2): 87-101
3. Kirtikar KR, Basu BD. Terminalia arjuna. In: Kirtikar KR, Basu BD, editors. Indian medicinal plants. Volume II. 2nd ed. Allahabad: Lalit Mohan Basu Publications, 1935: 1023-8
4. Singh B, Singh VP, Pandey VB, et al. A new triterpene glycoside from Terminalia arjuna. Planta Medica 1995; 61: 576-7
5. Kandil FE, Nassar MI. A tannin anticancer promoter from Terminalia arjuna. Phytochemistry 1998; 47: 1567-8 (Pubitemid 28242183)
6. Ali A, Abdullah ST, Hamid H, et al. Two new pentacyclic triterpenoid glycosides from the bark of Terminalia arjuna. Ind J Chem 2003; 42B: 2905-8
7. King FE, King TJ, Ross JM. The constituent of arjunoilc acid, a triterpene from Terminalia arjuna. J Chem Soc 1954; 3995-4003
8. Singh DV, Verma RK, Singh SC, et al. RP-LC determination of oleane derivatives in Terminalia arjuna. J Pharm Biomed Anal 2002; 28: 447-52 (Pubitemid 34465615)
9. Row LR, Murty PS, Rao GSRS, et al. Chemical examination of Terminalia species: Part XIII-Isolationa& structure determination of Arjunetin, from Terminalia arjuna. Ind J. Chem 1970; 8: 772-5
10. Chopra RN, Chopra IC, Handa KL, et al. (editors). Indigenous drugs of India. Kolkata: U.N. Dhur and Sons, 1958; pp.51-595
11. Singh N, Kapur KK, Singh SP, et al. Mechanism of cardiovascular action of Terminalia arjuna. Planta Med 1982; 45 (2): 102-4 (Pubitemid 12016567)
12. Takahashi S, Tanaka H, Hano Y, et al. Hypotensive effects in rats of hydrophilic extract from Terminalia arjuna containing tannin-related compounds. Phytother Res 1997; 1: 424-7 (Pubitemid 27389301)
13. Gauthaman K, Banerjee SK, Dinda AK, et al. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein. J Ethnopharmacol 2005; 96 (3): 403-9 (Pubitemid 41556590)
14. Dwivedi S, Somani PN, Chansouria JPN, et al. Cardioprotective effects of certain indigenous drugs in myocardial ischemia in rabbits. Indian J Exp Biol 1988; 26 (12): 969-75
15. Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna: a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine 2005; 12 (5): 391-3 (Pubitemid 40615335)
16. Gauthaman K, Maulik M, Kumari R, et al. Effect of chronic treatment with bark of Terminalia arjuna: A study on the isolated ischemic-reperfused rat heart. J. Ethnopharmacol 2001; 75 (2-3): 197-201 (Pubitemid 32303141)
17. Sumitra M, Manikandan P, Kumar DA, et al. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001; 224 (1-2): 135-42 (Pubitemid 32962659)
18. Khanna AK, Chander C, Kapoor NK. Terminalia arjuna: an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats. Phytother Res 1996; 10 (8): 663-6
19. Subramaniam S, Ramachandran S, Uthrapathi S, et al. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol 2011; 49 (4): 282-8
20. Subramaniam S, Subramaniam R, Rajapandian S, et al. Anti-atherogenic activity of ethanolic fraction of Terminalia arjuna bark on hypercholesterolemic rabbits. Evid Based Complement Alternat Med 2011; 487916
21. Kumar S, Enjamoori R, Jaiswal A, et al. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J Pharm Pharmacol 2009; 61 (11): 1529-36
22. Oberoi L, Akiyama T, Lee KH, et al. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine 2011 Feb 15; 18 (4): 259-6
23. Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Phys India 1994; 42 (4): 287-9
24. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J 1997; 49: 507-10 (Pubitemid 28100250)
25. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEngl J Med 1991; 325: 293-302
26. Bharani A, Ganguli A, Mathur LK, et al. Efficacy of Terminalia arjuna in chronic stable angina: a double blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J2002; 54 (2): 170-5 (Pubitemid 34664291)
27. Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998; 32 (6): 1657-64 (Pubitemid 28545205)
28. Dwivedi S, Aggarwal A, Agarwal MP, et al. Role of Terminalia arjuna in ischaemic mitral regurgitation. Int J Cardiol 2005 Apr 28; 100 (3): 507-8
29. Bharani A, Ahirwar LK, Jain N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J 2004; 6 (2): 123-8 (Pubitemid 39118430)
30. Raitakari OT, Adams MR, McCredie RJ, et al. Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. J Am Coll Cardiol 2000; 35 (6): 1616-21 (Pubitemid 30307508)
31. Neunteufl T, Priglinger U, Heher S, et al. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J AmColl Cardiol 2000; 35 (2): 277-83 (Pubitemid 30125514)
32. Rao BCS, Singh RH, Tripathi K. Effect of Terminalia arjuna (W&A) on regression of LVH in hypertensives: a clinical study. J Res Ayurveda Sidhha 2001; XXII (3-4): 216-27
33. Fagard RH, Celis H, Thijs L, et al. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension 2009; 54 (5): 1084-91
34. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol 1995; 49: 191-9
35. Greenberg B, Borghi C, Perrone S. Pharmacotherapeutic approaches for ecompensated heart failure: a role for the calcium sensitiser, levosimendan? Eur J Heart Fail 2003; 5 (1): 13-21 (Pubitemid 36210889)
36. Kontush A, Chapman MJ. Antiatherogenic small, dense HDL: guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 2006; 3 (3): 144-53
37. Gupta R, Singhal S, Goyle A, et al. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebocontrolled trial. J Assoc Physicians India 2001; 49: 231-5
38. Malik N, Dhawan V, Bahl A, et al. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease. Platelets 2009; 20 (3): 183-90
39. Sandhu JS, Shah B, Shenoy S, et al. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Ayurveda Res 2010 Jul; 1 (3): 144-9
40. Jayakumar K. Bottlenecks in standardisation of traditional system of medicine. Res J Medicinal Plants 2011; 5 (4): 443-7